These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11316669)

  • 21. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F; Kayiran P; Memioglu N; Tarim OF; Eren N; Erdem E
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary cortisol monitoring: determination of reference values in healthy children and application in asthmatic children.
    Nagakura T; Tanaka T; Arita M; Nishikawa K; Shigeta M; Wada N; Matsumoto T; Hiraba K; Fukuda N
    Allergy Asthma Proc; 2012; 33(4):362-9. PubMed ID: 22856637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high starting dose of budesonide inhalation suspension on serum cortisol concentration in young children with recurrent wheezing episodes.
    Volovitz B; Nussinovitch M
    J Asthma; 2003 Sep; 40(6):625-9. PubMed ID: 14579993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers.
    Wennergren G; Nordvall SL; Hedlin G; Möller C; Wille S; Asbrink Nilsson E
    Acta Paediatr; 1996 Feb; 85(2):183-9. PubMed ID: 8640047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled budesonide: placebo problems.
    Elwood T; Morris B
    Acad Emerg Med; 1998 Sep; 5(9):943-4. PubMed ID: 9754511
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.
    Ilangovan P; Pedersen S; Godfrey S; Nikander K; Noviski N; Warner JO
    Arch Dis Child; 1993 Mar; 68(3):356-9. PubMed ID: 8466238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway and systemic effects of soluble and suspension formulations of nebulized budesonide in asthmatic children.
    Basu K; Nair A; Williamson PA; Mukhopadhyay S; Lipworth BJ
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):436-41. PubMed ID: 19927544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How effective is the single-inhaler?].
    Gillissen A
    Dtsch Med Wochenschr; 2013 Aug; 138(33):1648. PubMed ID: 23913350
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma.
    Shrewsbury SB; Bosco AP; Uster PS
    Int J Pharm; 2009 Jan; 365(1-2):12-7. PubMed ID: 18786624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How much nebulised budesonide reaches infants and toddlers?
    Lødrup Carlsen KC; Nikander K; Carlsen KH
    Arch Dis Child; 1992 Sep; 67(9):1077-9. PubMed ID: 1417048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose titration of nebulized budesonide in young children.
    Vikre-Jørgensen J; Agertoft L; Pedersen S
    Pediatr Pulmonol; 1997 Apr; 23(4):270-7. PubMed ID: 9141112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of pulsed and breath-synchronized nebulization of budesonide as a means of reducing nebulizer wastage of drug.
    Nikander K; Turpeinen M; Wollmer P
    Pediatr Pulmonol; 2000 Feb; 29(2):120-6. PubMed ID: 10639202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of nebulized budesonide in severe exacerbation of bronchial asthma].
    Sereda VP; Svistov AS
    Klin Med (Mosk); 2004; 82(6):61-6. PubMed ID: 15344695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
    Kemp JP; Skoner DP; Szefler SJ; Walton-Bowen K; Cruz-Rivera M; Smith JA
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):231-9. PubMed ID: 10507269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of nebulized budesonide in hospitalized infants and children younger than 24 months with bronchiolitis.
    Chao LC; Lin YZ; Wu WF; Huang FY
    Acta Paediatr Taiwan; 2003; 44(6):332-5. PubMed ID: 14983653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of budesonide nebulising suspension compared to disodium cromoglycate in early childhood asthma.
    Zielen S; Rose MA; Bez C; Jarisch A; Reichenbach J; Hofmann D
    Curr Med Res Opin; 2006 Feb; 22(2):367-73. PubMed ID: 16466609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study].
    Tezuka J; Motomura C; Ikei J; Ide K; Kando N; Goto M; Taba N; Hayashi D; Murakami Y; Moriyasu Y; Soebijanto K; Shibata R; Okada K; Okada H; Nishima S
    Arerugi; 2008 Aug; 57(8):1034-42. PubMed ID: 18781108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
    Kunkel G; Chuchalin AG
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide Modulite: improving the changeover to CFC-free treatments.
    Magnussen H
    Respir Med; 2003 Nov; 97 Suppl D():S1-3. PubMed ID: 14753245
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial.
    Silverman M; Sheffer AL; Díaz PV; Lindberg B
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():14-20. PubMed ID: 16573704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.